Inspira Technologies 6-K Report: Showcasing Innovation at Arab Health Expo 2025
Key Information from the Financial Report (Form 6-K)
- Registrant Information:
- Company Name: Inspira Technologies Oxy B.H.N. Ltd.
- Address: 2 Ha-Tidhar St., Ra’anana 4366504, Israel.
- Commission File Number: 001-40303.
- Report Details:
- Type of Report: Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
- Report Date: January 7, 2025.
- Filing Purpose: This report includes a press release and is submitted as part of the company's regulatory obligations.
- Press Release:
- Title of Press Release: "Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai."
- Incorporation of Information: The first four paragraphs of the press release and the section titled “Forward-Looking Statements” are incorporated by reference into the company’s Registration Statements on Form F-3 and Form S-8.
- Exhibits:
- Exhibit 99.1: Copy of the press release issued on January 7, 2025, regarding the showcasing of the company's flagship technology at the Arab Health Expo 2025.
- Signatory:
- Date: January 7, 2025.
- Name: Dagi Ben-Noon.
- Title: Chief Executive Officer.
Insights:
- The press release indicates a strategic marketing effort by Inspira Technologies to showcase its technology at a significant healthcare event, which could enhance visibility and market opportunities.
- The filing demonstrates compliance with SEC regulations, ensuring transparency and accountability to investors and stakeholders.
- The incorporation of forward-looking statements suggests the company may be targeting future growth and innovation, which could be of interest to potential investors.